US 7368116
Method of enhancing a targeted immune response against tumors
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 7368116 (Method of enhancing a targeted immune response against tumors) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K39/00, A61K40/00